Ng Geraldine Y T, Hampson Evans Darryl C, Murdoch Linda J
Department of Neonatology, St George's Hospital, Tooting, London, UK.
Eur J Emerg Med. 2003 Dec;10(4):323-5. doi: 10.1097/00063110-200312000-00016.
Amiodarone is recommended by the International Liaison Committee on Resuscitation and has been adapted by the Resuscitation Council (UK) and the Advanced Life Support Group for use in paediatric advanced life support and advanced paediatric life support for the treatment of refractory supraventricular tachycardia. The International Liaison Committee on Resuscitation has stated that resuscitation guidelines should be evidence based. We present a case report of a cardiovascularly stable infant with supraventricular tachycardia who had a variety of arrthymias requiring cardiopulmonary resucitation for a prolonged period of time after loading with intravenous amiodarone. We believe that this report, together with other evidence, may suggest caution with the use of amiodarone.
国际复苏联合委员会推荐使用胺碘酮,英国复苏委员会和高级生命支持小组已采用该药物用于儿童高级生命支持和儿科高级生命支持,以治疗难治性室上性心动过速。国际复苏联合委员会指出,复苏指南应以证据为基础。我们报告一例心血管稳定的室上性心动过速婴儿病例,该婴儿在静脉注射胺碘酮负荷后出现多种心律失常,需要长时间进行心肺复苏。我们认为,本报告以及其他证据可能提示使用胺碘酮时需谨慎。